IL-15R -IgG1-Fc Enhances IL-2 and IL-15 Anti-tumor Action through NK and CD8+ T Cells Proliferation and Activation

Preassociation of IL-15 with IL-15R -IgG1-Fc Enhances Its Activity on Proliferation of NK and CD8+/CD44high T Cells and Its Antitumor Action

(2014) S. Dubois et al.   JOURNAL OF IMMUNOLOGY

Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases

(2009) Y. Xu et al.   BLOOD

Strategies to enhance rituximab anti-tumor activity in the treatment of CD20-positive B-cell neoplasms

(2009) Wasif Riaz et al.   IMMUNOLOGIC RESEARCH

Application of tissue-specific NK and NKT cell activity for tumor immunotherapy

(2009) Jeff J. Subleski et al.   JOURNAL OF AUTOIMMUNITY

In Vivo Expansion of Activated Naive CD8+ T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy

(2009) J. Tomala et al.   JOURNAL OF IMMUNOLOGY

Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer

(2009) M. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Primer: making sense of T-cell memory

(2008) Peter CL Beverley   Nature clinical practice. Rheumatology